Trademark: 97489717
Word
ADTHERA
Status
Registered
Status Code
700
Status Date
Tuesday, April 23, 2024
Serial Number
97489717
Registration Number
7362949
Registration Date
Tuesday, April 23, 2024
Mark Type
4
Filing Date
Tuesday, July 5, 2022
Published for Opposition
Tuesday, November 7, 2023

Trademark Owner History
ADTHERA BIO LIMITED - Original Registrant
Delin Ventures Advisors Limited - Original Applicant

Classifications
40 Cell culture, cell therapy and gene therapy manufacturing services for others; manufacturing of advanced therapy medicinal products (ATMPs) for others; custom manufacture of therapeutic drugs, medicines, cell therapies and gene therapies for others; custom manufacture of cell culture products for others; rental and leasing of cell culture, cell therapy and gene therapy manufacturing apparatus; information, advice and consultancy in relation to all the aforesaid
9 Downloadable software and software applications used to deliver information and content regarding advanced therapy medicinal products (ATMPs), cell and gene therapy products and services; downloadable software and software applications for use in pharmaceutical manufacturing, drug development, and delivery of therapies to patients in the fields of advanced therapy medicinal products, cell therapy and gene therapy
42 Biotechnology research; design and development of pharmaceutical products in the field of biotechnology; scientific research for medical purposes in the field of cell culture, cell therapy and gene therapy; scientific research consultancy in relation to cell culture, cell therapy, and gene therapy manufacturing; development of cell culture, cell therapy and gene therapy processes for others; scientific research in the nature of conducting clinical trials for others in the field of cell culture, cell therapy and gene therapy services; scientific research in the nature of conducting clinical trials for others; pharmaceutical drug development services; rental of scientific apparatus and instruments; development of processes for cell culture, cell therapy and gene therapy pharmaceutical manufacturing; development of processes for manufacturing of advanced therapy medicinal products; design and development of scientific cell culture, cell therapy and gene therapy equipment and apparatus; design and development of scientific advanced therapy medicinal products, pharmaceutical manufacturing equipment and apparatus; software as a service (SaaS) featuring software for pharmaceutical manufacturing and drug development in the field of advanced therapy medicinal products, cell therapy, gene therapy and cell culture; providing temporary use of, online non-downloadable software and online non-downloadable software platforms for pharmaceutical manufacturing and drug development in the field of advanced therapy medicinal products, cell therapy, gene therapy and cell culture; software as a service (SaaS) featuring software for reviewing, purchasing, ordering, tracking, delivering, monitoring and analysing advanced therapy medicinal products, cell therapy, gene therapy and cell culture products and services; platform as a service featuring computer software platforms for reviewing, purchasing, ordering, tracking, delivering, monitoring and analysing advanced therapy medicinal products, cell therapy, gene therapy and cell culture products and services; providing temporary use of online non-downloadable software and online non-downloadable software platforms for reviewing, purchasing, ordering, tracking, delivering, monitoring and analysing advanced therapy medicinal products, cell therapy, gene therapy and cell culture products and services; providing information, advice and consultancy in relation to all the aforesaid

Trademark Events
Jul 8, 2022
New Application Entered
Jul 8, 2022
Teas Voluntary Amendment Received
Jul 25, 2022
New Application Office Supplied Data Entered
Aug 15, 2022
Assigned To Lie
Aug 15, 2022
Preliminary/Voluntary Amendment - Entered
Apr 18, 2023
Assigned To Examiner
May 2, 2023
Non-Final Action Written
May 2, 2023
Non-Final Action E-Mailed
May 2, 2023
Notification Of Non-Final Action E-Mailed
Aug 2, 2023
Teas Response To Office Action Received
Aug 2, 2023
Correspondence Received In Law Office
Aug 2, 2023
Teas/Email Correspondence Entered
Aug 9, 2023
Automatic Update Of Assignment Of Ownership
Aug 30, 2023
Examiners Amendment -Written
Aug 30, 2023
Examiners Amendment E-Mailed
Aug 30, 2023
Notification Of Examiners Amendment E-Mailed
Aug 30, 2023
Examiner's Amendment Entered
Sep 27, 2023
Approved For Pub - Principal Register
Oct 3, 2023
Electronic Record Review Complete
Sep 29, 2023
On Hold - Electronic Record Review Required
Nov 7, 2023
Published For Opposition
Oct 18, 2023
Notification Of Notice Of Publication E-Mailed
Nov 7, 2023
Official Gazette Publication Confirmation E-Mailed
Dec 5, 2023
Extension Of Time To Oppose Received
Mar 17, 2024
Extension Of Time To Oppose Process - Terminated
Apr 23, 2024
Registered-Principal Register
Apr 23, 2024
Notice Of Registration Confirmation Emailed

Trademark Alertz updated from USPTO on 2030-01-24